BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17363045)

  • 1. Unexpected long-term survival without evidence of disease after salvage chemotherapy for recurrent metastatic cervical cancer: a case series.
    Khoury-Collado F; Bowes RJ; Jhamb N; Aghajanian C; Abu-Rustum NR
    Gynecol Oncol; 2007 Jun; 105(3):823-5. PubMed ID: 17363045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
    Singhal RM; Jindel R; Gupta AK
    Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
    Mabuchi S; Morishige K; Fujita M; Tsutsui T; Sakata M; Enomoto T; Kimura T
    Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy.
    Kastritis E; Bamias A; Bozas G; Koutsoukou V; Voulgaris Z; Vlahos G; Rodolakis A; Gika D; Papadimitriou C; Dimopoulos MA
    Gynecol Oncol; 2007 Feb; 104(2):372-6. PubMed ID: 17030353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial of ifosfamide, 5-fluorouracil, and leucovorin in recurrent uterine cervical cancer.
    Stornes I; Mejlholm I; Jakobsen A
    Gynecol Oncol; 1994 Oct; 55(1):123-5. PubMed ID: 7959252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial.
    Downs LS; Chura JC; Argenta PA; Judson PL; Ghebre R; Geller MA; Carson LF
    Gynecol Oncol; 2011 Feb; 120(2):265-9. PubMed ID: 21145100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
    Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
    Geburtshilfe Frauenheilkd; 1989 Dec; 49(12):1050-5. PubMed ID: 2693187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.
    Wheelock JB; Krebs HB; Goplerud DR; Myers M
    Obstet Gynecol; 1985 Sep; 66(3):410-2. PubMed ID: 4040622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
    Kollmannsberger C; Bokemeyer C
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):167-72. PubMed ID: 18685416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma.
    Lin CC; Yeh KH; Yang CH; Hsu C; Tsai YC; Hsu WL; Cheng AL; Hsu CH
    Anticancer Drugs; 2007 Jul; 18(6):703-8. PubMed ID: 17762400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for recurrent and metastatic cervical cancer with standard-dose methotrexate-leucovorin, bleomycin and cis-platinum.
    Vogl SE; Seltzer V; Camacho F; Davis TE
    J Reprod Med; 1986 May; 31(5):327-9. PubMed ID: 2427717
    [No Abstract]   [Full Text] [Related]  

  • 15. Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma.
    Hsiao SM; Chen CA; Hsu C; Lin HH; Hsieh CY; Wei LH
    Anticancer Res; 2008; 28(3B):1887-91. PubMed ID: 18630476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.
    Hancock SB; Krempl GA; Canfield V; Bogardus C; Kojouri K; Kaneaster SK; Medina JE
    Laryngoscope; 2008 Aug; 118(8):1357-61. PubMed ID: 18528311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraarterial infusion of oncostasis in patients with recurrent cervical cancer].
    Shimizu Y; Hasumi K; Miura S; Okudaira Y; Masubuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):511-4. PubMed ID: 3373079
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy for recurrent and metastatic cervical cancer.
    Tao X; Hu W; Ramirez PT; Kavanagh JJ
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of neoadjuvant chemotherapy in the treatment of patients with stage IIIB cervical cancer].
    Gorchev G; Kornovski Ia
    Akush Ginekol (Sofiia); 2003; 42(6):21-4. PubMed ID: 15067810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.